HURRICANE CAPITAL ADVISORS LLC’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$518K Sell
2,060
-246
-11% -$52.9K 0.13% 159
2026
Q1
$502K Buy
2,306
+146
+7% +$32.4K 0.16% 116
2025
Q4
$494K Sell
2,160
-396
-15% -$90.2K 0.16% 102
2025
Q3
$592K Buy
2,556
+120
+5% +$24.4K 0.15% 126
2025
Q2
$452K Hold
2,436
– – 0.11% 130
2025
Q1
$510K Buy
2,436
+101
+4% +$19.6K 0.17% 99
2024
Q4
$415K Buy
2,335
+100
+4% +$18.4K 0.12% 133
2024
Q3
$441K Sell
2,235
-1,000
-31% -$187K 0.16% 113
2024
Q2
$555K Sell
3,235
-250
-7% -$41.4K 0.19% 80
2024
Q1
$635K Buy
3,485
+1,250
+56% +$215K 0.18% 81
2023
Q4
$346K Buy
+2,235
New +$326K 0.13% 106

Other funds holding ABBV

HURRICANE CAPITAL ADVISORS LLC's ABBV Position: Q2 2026 in Review

HURRICANE CAPITAL ADVISORS LLC reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $52.9K and leaving 2,060 shares worth $518K. The position accounts for 0.13% of the portfolio, ranked #159.

HURRICANE CAPITAL ADVISORS LLC first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $635K in Q1 2024. 4,252 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HURRICANE CAPITAL ADVISORS LLC held 2,060 shares of AbbVie worth $518K as of Q2 2026.
  • HURRICANE CAPITAL ADVISORS LLC sold 246 AbbVie shares in Q2 2026, an estimated $52.9K.
  • AbbVie made up 0.13% of HURRICANE CAPITAL ADVISORS LLC's portfolio in Q2 2026, its #159 holding.
  • HURRICANE CAPITAL ADVISORS LLC first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • HURRICANE CAPITAL ADVISORS LLC's AbbVie position peaked at $635K in Q1 2024.
  • 4,252 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HURRICANE CAPITAL ADVISORS LLC's 13F filing for Q2 2026, filed 3 Nov 2026.